EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Metformin and Adipose Tissue: A Multifaceted Regulator in Metabolism, Inflammation, and Regeneration

Xin-Li Wei, Ming-Hao Tao, Run-Hao Li, Shi-Hui Ge, Wei Xiao

Endocrinology and Metabolism · 31.08.2025 · 40 (4) · 523-538

DOI: 10.3803/enm.2025.2371 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism, erschienen am 31.08.2025. Verfasst von Xin-Li Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical School, Henan University of Chinese Medicine, Zhengzhou, China. Hauptthemen laut MEDLINE: Metformin, Inflammation, Adipose Tissue, Hypoglycemic Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metformin, a first-line treatment for type 2 diabetes mellitus (T2DM), has garnered attention due to its pleiotropic effects beyond glycemic control. In addition to improving insulin sensitivity and inhibiting hepatic gluconeogenesis, metformin modulates inflammation, oxidative stress, and cellular metabolism, particularly within adipose tissue. Adipose tissue is a crucial endocrine organ that plays a central role in metabolic homeostasis and is integral to obesity and T2DM pathogenesis. This review discusses the actions of metformin on white and brown adipose tissues, extracellular matrix remodeling, mature adipocytes, and adipose-derived stem cells. Through both AMP-activated protein kinase-dependent and independent pathways, metformin influences adipogenesis, lipolysis, adipokine secretion, fibrosis, and cellular senescence. We also focus on how the drug concentration influences its biological effects, emphasizing the necessity of physiologically relevant experimental models. These insights deepen our understanding of metformin’s therapeutic potential in metabolic and age-related disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminInflammationAdipose TissueHypoglycemic AgentsRegenerationHumansAnimalsDiabetes Mellitus, Type 2

Stichwörter der Autor:innen

Adipose tissueMetforminPharmacology

Substanzen

MetforminHypoglycemic Agents

Autor:innen und Institutionen

  • The First Clinical Medical School, Henan University of Chinese Medicine, Zhengzhou, China.
  • State Key Laboratory of Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Lianyungang, China.
  • Department of Endocrinology and Metabolism, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Human Anatomy & Histoembryology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Department of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China.

Zitieren

APA

Wei, X. L., Tao, M. H., Li, R. H., Ge, S. H., & Xiao, W. (2025). Metformin and Adipose Tissue: A Multifaceted Regulator in Metabolism, Inflammation, and Regeneration. Endocrinology and Metabolism, 40(4), 523-538. https://doi.org/10.3803/enm.2025.2371

Vancouver

Wei XL, Tao MH, Li RH, Ge SH, Xiao W. Metformin and Adipose Tissue: A Multifaceted Regulator in Metabolism, Inflammation, and Regeneration. Endocrinology and Metabolism. 2025;40(4):523-538. doi:10.3803/enm.2025.2371

BibTeX
@article{Wei2025,
  author = {Wei, Xin-Li and Tao, Ming-Hao and Li, Run-Hao and Ge, Shi-Hui and Xiao, Wei},
  title = {Metformin and Adipose Tissue: A Multifaceted Regulator in Metabolism, Inflammation, and Regeneration},
  journal = {Endocrinology and Metabolism},
  year = {2025},
  volume = {40},
  number = {4},
  pages = {523--538},
  doi = {10.3803/enm.2025.2371}
}
Kostenlos starten →